Firms/companies
RBI approves merger of ING Vysya with Kotak Mahindra
01 Apr 2015
The merged entity, with 1,214 branches, a wide-spread pan-India network and a combined employee strength of nearly 40,000, is now the country’s fourth largest private sector lender
Facebook violating EU privacy norms, finds Belgian study
01 Apr 2015
The BPC report finds that Facebook tracks everyone, even logged-out users or people who don’t have an account, primarily through the use of cookies and the ‘like’ button which is found on more than 13 million websites worldwide
Facebook violating EU privacy norms, finds Belgian study
01 Apr 2015
The BPC report finds that Facebook tracks everyone, even logged-out users or people who don’t have an account, primarily through the use of cookies and the ‘like’ button which is found on more than 13 million websites worldwide
Philips to sell majority stake in lighting components division for $2.8 bn
31 Mar 2015
Philips today agreed to sell a majority stake in its lighting components division to private equity investors for $2.8 billion as part of its plan to focus on the consumer health-care market
Adani meets Queensland premier amidst fresh green threat to mine project
31 Mar 2015
Adani says the mine will create 10,000 jobs and fetch $22 billion in taxes and royalties to Queensland state, but the environment group argues that the 280 sq km Carmichael mine would destry the country's ecosystem and pollute the world
Adani meets Queensland premier amidst fresh green threat to mine project
31 Mar 2015
Adani says the mine will create 10,000 jobs and fetch $22 billion in taxes and royalties to Queensland state, but the environment group argues that the 280 sq km Carmichael mine would destry the country's ecosystem and pollute the world
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles